SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-044858
Filing Date
2022-04-12
Accepted
2022-04-12 09:07:53
Documents
14
Period of Report
2022-04-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2212510d1_8k.htm   iXBRL 8-K 27654
2 EXHIBIT 99.1 tm2212510d1_ex99-1.htm EX-99.1 7444
6 GRAPHIC tm2212510d1_ex99-1img001.jpg GRAPHIC 3495
  Complete submission text file 0001104659-22-044858.txt   214110

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20220412.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20220412_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20220412_pre.xml EX-101.PRE 22601
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2212510d1_8k_htm.xml XML 3481
Mailing Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 22821212
SIC: 2836 Biological Products, (No Diagnostic Substances)